ELI LILLY & CO (LLY)
Clinical trial NCT06817356 updates: 1. primary completion date: 2026-08-01 → 2026-03-19 2. enrollment: 300 → 308 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06817356 updates: 1. primary completion date: 2026-08-01 → 2026-03-19 2. enrollment: 300 → 308 participants 3. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical